false
0001435064
0001435064
2026-01-08
2026-01-08
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): January
8, 2026

CEMTREX,
INC.
(Exact Name of Registrant as Specified in Charter)
| Delaware |
|
001-37464 |
|
30-0399914 |
(State
or other jurisdiction
of
incorporation) |
|
(Commission
File
Number) |
|
(IRS
Employer
Identification
No.) |
135
Fell Court
Hauppauge,
NY |
|
11788 |
| (Address
of principal executive offices) |
|
(Zip
Code) |
Registrant’s
telephone number, including area code: (631)
756-9116
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4© under the Exchange Act (17 CFR 240.13 ©(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Common
stock |
|
CETX |
|
Nasdaq
Capital Market |
Indicate by check
mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this
chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
2.01 Completion of Acquisition or Disposition of Assets
As
previously disclosed in the Current Report on Form 8-K filed on November 19, 2025, on November 13, 2025, Cemtrex, Inc. (the “Company”)
entered into a Share Purchase Agreement (the “Agreement”) with Karl F. Kiefer, an individual resident of Texas (the “Seller”),
and Invocon, Inc., a Texas corporation (“Invocon”), pursuant to which the Company agreed to acquire 100% of the issued and
outstanding shares of Invocon for a purchase price of $7,060,000 in cash.
On
January 8, 2026, the Company completed the acquisition of Invocon. As a result of the transaction, Invocon became a wholly-owned subsidiary
of the Company. The purchase price of $7,060,000 was paid in cash at closing.
The
Agreement has been included to provide investors with information regarding its terms. The representations, warranties, and covenants
contained in the Agreement were made only for the purposes of the Agreement, were made as of specific dates, were made solely for the
benefit of the parties to the Agreement, and may not have been intended to be statements of fact, but rather as a method of allocating
risk and governing the contractual rights and relationships among the parties to the Agreement. In addition, such representations, warranties,
and covenants may have been qualified by certain disclosures not reflected in the text of the Agreement and may apply standards of materiality
and other qualifications and limitations in a way that is different from what may be viewed as material by the Company’s shareholders.
None of the Company’s shareholders or any other third party should rely on the representations, warranties, and covenants, or any
descriptions thereof, as characterizations of the actual state of facts or conditions of the Company, Invocon, or any of their respective
subsidiaries or affiliates. Moreover, information concerning the subject matter of representations and warranties may change after the
date of the Agreement, which subsequent information may or may not be fully reflected in the Company’s public disclosures. The
Agreement should not be read alone, but should instead be read in conjunction with the other information regarding the Company that is
or will be contained in, or incorporated by reference into, the Forms 10-K, Forms 10-Q, Forms 8-K, and other documents that the Company
files or has filed with the SEC.
The
foregoing description of the Agreement and the transaction is a summary, does not purport to be complete, and is qualified in its entirety
by reference to the full text of the Agreement, a copy of which was filed as Exhibit 2.1 to the Current Report on Form 8-K filed with
the Securities and Exchange Commission on November 19, 2025 and is incorporated by reference herein.
Item
8.01 Other Events
On January 8, 2026, the Company issued a press release announcing the completion of the acquisition of Invocon, Inc. A copy of the press
release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Item
9.01 Financial Statements and Exhibits
(a)
Financial Statements of Businesses Acquired. The financial statements of Invocon that may be required by Item 9.01(a) to this Current
Report on Form 8-K will be filed by amendment within 71 calendar days after the date this report on Form 8-K must be filed.
(b)
Pro Forma Financial Information. The pro forma financial information that may be required by Item 9.01(b) to this Current Report on Form
8-K will be filed by amendment within 71 calendar days after the date this report on Form 8-K must be filed.
(d)
Exhibits
| Exhibit
No. |
|
Description |
| 2.1 |
|
Share Purchase Agreement, dated November 13, 2025 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on November 19, 2025) |
| 99.1 |
|
Press
Release dated January 8, 2026 |
| 104 |
|
Cover
Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| |
CEMTREX,
INC. |
| |
|
| Date:
January 8, 2026 |
By: |
/s/
Saagar Govil |
| |
|
Saagar
Govil |
| |
|
Chairman,
President and Chief Executive Officer |